Risk Factors for Therapeutic Failure and One-Year Mortality in Patients with Intramedullary Nail-Associated Infection after Trochanteric and Subtrochanteric Hip Fracture Repair

Despite the implications of trochanteric and subtrochanteric intramedullary (IM) nail infection for patients with hip fracture, little is known about risk factors for therapeutic failure and mortality in this population. We performed a retrospective observational analysis including patients diagnose...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Bernadette Pfang (Author), Marco A. Villegas García (Author), Antonio Blanco García (Author), Álvaro Auñón Rubio (Author), Jaime Esteban (Author), Joaquín García Cañete (Author)
Hōputu: Pukapuka
I whakaputaina: MDPI AG, 2024-05-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ea3b23c859d94c76bde9fc57024cb1dc
042 |a dc 
100 1 0 |a Bernadette Pfang  |e author 
700 1 0 |a Marco A. Villegas García  |e author 
700 1 0 |a Antonio Blanco García  |e author 
700 1 0 |a Álvaro Auñón Rubio  |e author 
700 1 0 |a Jaime Esteban  |e author 
700 1 0 |a Joaquín García Cañete  |e author 
245 0 0 |a Risk Factors for Therapeutic Failure and One-Year Mortality in Patients with Intramedullary Nail-Associated Infection after Trochanteric and Subtrochanteric Hip Fracture Repair 
260 |b MDPI AG,   |c 2024-05-01T00:00:00Z. 
500 |a 10.3390/antibiotics13050463 
500 |a 2079-6382 
520 |a Despite the implications of trochanteric and subtrochanteric intramedullary (IM) nail infection for patients with hip fracture, little is known about risk factors for therapeutic failure and mortality in this population. We performed a retrospective observational analysis including patients diagnosed with trochanteric and subtrochanteric IM nail infection at a Spanish academic hospital during a 10-year period, with a minimum follow-up of 22 months. Of 4044 trochanteric and subtrochanteric IM nail implants, we identified 35 cases of infection during the study period (0.87%), 17 of which were chronic infections. Patients with therapeutic failure (n = 10) presented a higher average Charlson Comorbidity Index (CCI) (5.40 vs. 4.21, <i>p</i> 0.015, CI 0.26-2.13) and higher rates of polymicrobial (OR 5.70, <i>p</i> 0.033, CI 1.14-28.33) and multidrug-resistant (OR 7.00, <i>p</i> 0.027, CI 1.24-39.57) infections. Upon multivariate analysis, polymicrobial infection and the presence of multidrug-resistant pathogens were identified as independent risk factors for therapeutic failure. Implant retention was associated with an increased risk of failure in chronic infection and was found to be an independent risk factor for overall one-year mortality in the multivariate analysis. Our study highlights the importance of broad-spectrum empirical antibiotics as initial treatment of trochanteric and subtrochanteric IM nail-associated infection while awaiting microbiological results. It also provides initial evidence for the importance of implant removal in chronic IM-nail infection. 
546 |a EN 
690 |a hip osteosynthesis 
690 |a infection 
690 |a intramedullary nail 
690 |a pertrochanteric fracture 
690 |a subtrochanteric fracture 
690 |a healthcare-associated infection 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 13, Iss 5, p 463 (2024) 
787 0 |n https://www.mdpi.com/2079-6382/13/5/463 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/ea3b23c859d94c76bde9fc57024cb1dc  |z Connect to this object online.